Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
209.52
-1.47 (-0.70%)
At close: Mar 18, 2026, 4:00 PM EDT
209.52
0.00 (0.00%)
After-hours: Mar 18, 2026, 4:10 PM EDT
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$245.00
Upside
+16.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Initiates $244 | Strong Buy | Initiates | $244 | +16.46% | Mar 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $275 → $277 | Buy | Maintains | $275 → $277 | +32.21% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $231 → $239 | Strong Buy | Maintains | $231 → $239 | +14.07% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $234 → $235 | Buy | Maintains | $234 → $235 | +12.16% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +9.77% | Dec 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +28.87% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $185 → $234 | Buy | Maintains | $185 → $234 | +11.68% | Nov 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +31.25% | Nov 7, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $175 → $220 | Strong Buy | Maintains | $175 → $220 | +5.00% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $206 → $231 | Strong Buy | Maintains | $206 → $231 | +10.25% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $190 → $250 | Buy | Maintains | $190 → $250 | +19.32% | Nov 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $167 → $190 | Buy | Maintains | $167 → $190 | -9.32% | Sep 3, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $160 → $175 | Strong Buy | Maintains | $160 → $175 | -16.48% | Sep 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $157 → $206 | Strong Buy | Maintains | $157 → $206 | -1.68% | Aug 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $155 → $185 | Buy | Maintains | $155 → $185 | -11.70% | Aug 8, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $162 → $167 | Buy | Maintains | $162 → $167 | -20.29% | Aug 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.